Compile Data Set for Download or QSAR
maximum 50k data
Found 7 Enz. Inhib. hit(s) with all data for entry = 8874
TargetD(2) dopamine receptor(Homo sapiens (Human))
Xuanwu Hospital Of Capital Medical University

US Patent
LigandPNGBDBM425972(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(6-fluoro-be...)
Affinity DataIC50:  51.3nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Xuanwu Hospital Of Capital Medical University

US Patent
LigandPNGBDBM425970(5-hydroxy-2-(4-fluorophenyl)-7-(4-(4-(2-methoxyphe...)
Affinity DataIC50:  57.3nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Xuanwu Hospital Of Capital Medical University

US Patent
LigandPNGBDBM425973(5-hydroxy-2-(4-fluorophenyl)-7-(4-(4-(6-fluoro-ben...)
Affinity DataIC50:  87.7nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Xuanwu Hospital Of Capital Medical University

US Patent
LigandPNGBDBM425975(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(6-fluoro-be...)
Affinity DataIC50:  116nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Xuanwu Hospital Of Capital Medical University

US Patent
LigandPNGBDBM425967(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(2-methoxyph...)
Affinity DataIC50:  205nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Xuanwu Hospital Of Capital Medical University

US Patent
LigandPNGBDBM425971(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(2-methoxyph...)
Affinity DataIC50:  220nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Xuanwu Hospital Of Capital Medical University

US Patent
LigandPNGBDBM425969(5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(2-methoxyph...)
Affinity DataIC50:  346nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent